Nuformix (LON:NFX) Trading Down 32.4% – What’s Next?

Nuformix plc (LON:NFX)’s share price traded down 32.4% during trading on Wednesday . The stock traded as low as GBX 0.10 ($0.00) and last traded at GBX 0.10 ($0.00). 343,525,563 shares changed hands during mid-day trading, an increase of 375% from the average session volume of 72,272,914 shares. The stock had previously closed at GBX 0.15 ($0.00).

Nuformix Stock Up 1.3 %

The stock has a 50 day moving average price of GBX 0.06 and a 200 day moving average price of GBX 0.10. The company has a quick ratio of 3.35, a current ratio of 1.12 and a debt-to-equity ratio of 1.17. The stock has a market capitalization of £622,675.60, a price-to-earnings ratio of -1.63 and a beta of 1.22.

Nuformix (LON:NFX) last released its quarterly earnings results on Wednesday, January 29th. The company reported GBX (0.46) (($0.01)) earnings per share (EPS) for the quarter.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.